Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

Detalles Bibliográficos
Autores principales: Immisch, Lena, Papafotiou, George, Popp, Oliver, Mertins, Philipp, Blankenstein, Thomas, Willimsky, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016299/
https://www.ncbi.nlm.nih.gov/pubmed/36918223
http://dx.doi.org/10.1136/jitc-2023-006784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016299/
https://www.ncbi.nlm.nih.gov/pubmed/36918223
http://dx.doi.org/10.1136/jitc-2023-006784

Ejemplares similares